No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
QGEN240816C45000
- 0.75
- -0.10-11.76%
15min DelayClose Jul 22 16:00 ET
0.75High0.66Low
0.70Open0.85Pre Close64 Volume3.85K Open Interest45.00Strike Price4.47KTurnover39.58%IV8.05%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.75Extrinsic Value100Contract SizeAmericanOptions Type0.3086Delta0.0800Gamma51.32Leverage Ratio-0.0327Theta0.0084Rho15.84Eff Leverage0.0391Vega
Intraday
- 5D
- Daily
News
NIH Outlays Rise by 5% in June, Says Baird
These Are the Stocks With the Highest Increase in Short Interest Within Life Sciences and Diagnostics - Baird
Morgan Stanley Maintains Qiagen NV(QGEN.US) With Buy Rating, Cuts Target Price to $47.62
Morgan Stanley analyst Aisyah Noor maintains $Qiagen NV(QGEN.US)$ with a buy rating, and adjusts the target price from $51 to $47.62.According to TipRanks data, the analyst has a success rate of 33.3%
QIAGEN Announces Partnership With The Snow Molecular Anthropology Lab At The University Of Montana In The Fields Of Human Identification And Forensics To Enhance The Identification Of Human Remains
QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA))))) today announced a partnership with the Snow Molecular Anthropology Lab at the University of Montana in the fields of human identification and fore
Express News | Qiagen NV : Morgan Stanley Cuts Target Price to $47 From $51
QIAGEN N.V. to Release Results for Q2 2024 and Hold Webcast
Venlo, The Netherlands, July 02, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE:QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the second quarter 2024. Press release date / time: Wednesday,
Comments
Qiagen's high P/E ratio is worrisome due to its poor earnings forecast. Despite the high P/E, investors retain their shares, but this earnings growth rate may eventually impact the share price. The high P/E and future earnings predictions pose a substantial risk to shareholders and potential investors.
There's Reason For Concern Over Qiagen N.V.'s (NYSE:QGEN) PriceQiagen's performance is strong due to strategic profit reinvestment, leading to significant earnings growth. Its respectable ROE contributes to a net income increase. Yet, forecasts anticipate a slowdown in future earnings growth.
2
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $SolarEdge Technologies(SEDG.US$ - up 7.31%
2. $Kohl's Corp(KSS.US$ - up 4.46%
3. $DuPont(DD.US$ - up 4.38%
4. $Welltower Inc(WELL.US$ - up 4.02%
5. $CNH Industrial(CNHI.US$ - up 3.18%
6. $Planet Fitness(PLNT.US$ - up 3.46%
7. $Qiagen NV(QGEN.US$ - up 2.35%
8. $Taiwan Semiconductor(TSM.US$ - up 2.05...
Gap Ups
1. $SolarEdge Technologies(SEDG.US$ - up 7.31%
2. $Kohl's Corp(KSS.US$ - up 4.46%
3. $DuPont(DD.US$ - up 4.38%
4. $Welltower Inc(WELL.US$ - up 4.02%
5. $CNH Industrial(CNHI.US$ - up 3.18%
6. $Planet Fitness(PLNT.US$ - up 3.46%
7. $Qiagen NV(QGEN.US$ - up 2.35%
8. $Taiwan Semiconductor(TSM.US$ - up 2.05...
+17
18
Gapping up
$Qiagen NV(QGEN.US$ +3.4% (the biotech company raised its full-year outlook, pointing to particular strength in its non-Covid product portfolio.)
$Lordstown Motors(RIDE.US$ +14.6% (contract manufacturer Foxconn will invest up to $170 million in the electric vehicle maker and become its largest shareholder.)
$DuPont(DD.US$ +3.7% (the industrial materials maker beat top and bottom line estimates for the third quarter. Du...
$Qiagen NV(QGEN.US$ +3.4% (the biotech company raised its full-year outlook, pointing to particular strength in its non-Covid product portfolio.)
$Lordstown Motors(RIDE.US$ +14.6% (contract manufacturer Foxconn will invest up to $170 million in the electric vehicle maker and become its largest shareholder.)
$DuPont(DD.US$ +3.7% (the industrial materials maker beat top and bottom line estimates for the third quarter. Du...
9
1
Read more